- Open Access
Genomic landscape of prominent XDR Acinetobacter clonal complexes from Dhaka, Bangladesh
BMC Genomics volume 23, Article number: 802 (2022)
Acinetobacter calcoaceticus-A. baumannii (ACB) complex pathogens are known for their prevalence in nosocomial infections and extensive antimicrobial resistance (AMR) capabilities. While genomic studies worldwide have elucidated the genetic context of antibiotic resistance in major international clones (ICs) of clinical Acinetobacter spp., not much information is available from Bangladesh. In this study, we analysed the AMR profiles of 63 ACB complex strains collected from Dhaka, Bangladesh. Following this, we generated draft genomes of 15 of these strains to understand the prevalence and genomic environments of AMR, virulence and mobilization associated genes in different Acinetobacter clones.
Around 84% (n = 53) of the strains were extensively drug resistant (XDR) with two showing pan-drug resistance. Draft genomes generated for 15 strains confirmed 14 to be A. baumannii while one was A. nosocomialis. Most A. baumannii genomes fell under three clonal complexes (CCs): the globally dominant CC1 and CC2, and CC10; one strain had a novel sequence type (ST). AMR phenotype-genotype agreement was observed and the genomes contained various beta-lactamase genes including blaOXA-23 (n = 12), blaOXA-66 (n = 6), and blaNDM-1 (n = 3). All genomes displayed roughly similar virulomes, however some virulence genes such as the Acinetobactin bauA and the type IV pilus gene pilA displayed high genetic variability. CC2 strains carried highest levels of plasmidic gene content and possessed conjugative elements carrying AMR genes, virulence factors and insertion sequences.
This study presents the first comparative genomic analysis of XDR clinical Acinetobacter spp. from Bangladesh. It highlights the prevalence of different classes of beta-lactamases, mobilome-derived heterogeneity in genetic architecture and virulence gene variability in prominent Acinetobacter clonal complexes in the country. The findings of this study would be valuable in understanding the genomic epidemiology of A. baumannii clones and their association with closely related pathogenic species like A. nosocomialis in Bangladesh.
Acinetobacter is a diverse genus consisting of more than 50 species, the majority of which are harmless environmental bacteria. However, a handful of Acinetobacter spp., belonging to the Acinetobacter calcoaceticus-A. baumannii (ACB) complex, pose a significant public health burden due to their association with hospital-acquired infections (HAI). Among ACB complex pathogens, A. baumannii is frequently encountered in intensive care units (ICUs) of hospitals where it usually infects debilitated patients with impaired host defences and disrupted normal flora . A. baumannii most commonly manifests in hospital-acquired pneumonia and bloodstream infections while also contributing to urinary tract infections, meningitis and wound infections. Other members of the ACB complex, i.e., A. pitti, A. calcoaceticus, A. nosocomialis (formerly known as A. baumannii 13TU) and A. seifertii are less frequently encountered in the clinical setting but remain central to understanding Acinetobacter related disease epidemiology [2, 3].
A. baumannii has built a formidable global reputation due its robust antimicrobial resistance (AMR) capabilities against a wide range of antibiotics including carbapenems, making it a priority organism for the World Health Organization (WHO) [4, 5]. Carbapenem resistance in A. baumannii is mainly mediated by the carbapenem-hydrolyzing class D beta-lactamases (CHDLs- Ambler class D), which is segregated into several varieties (blaOXA-23-like, blaOXA-40-like, blaOXA-51-like, blaOXA-58-like and blaOXA-143-like), and less frequently by metallo-beta-lactamases (MBLs- Ambler class B). Since A. baumannii is an opportunistic pathogen, it does not usually present traditional pathogenic traits such as toxicity, but instead ensures its persistence in nosocomial settings through immune evasion, biofilm formation and resistance to antimicrobials . A. baumannii’s genomic epidemiology is largely defined by a number of dominant international clones (ICs), each consisting of a closely related group of sequence types (STs) . With whole genome sequencing (WGS) becoming an increasingly routine and accessible application in understanding infectious disease epidemiology, many international comparative genomics studies on A. baumannii have elucidated the genetic environments of AMR genes (ARGs) and virulence factors in prominent Acinetobacter global clones [8,9,10].
In contrast, there are no genome-scale comparative studies of A. baumannii strains in Bangladesh where Acinetobacter spp. has been reported as a common causative agent of nosocomial infections [1, 11]. To date, most studies on clinical Acinetobacter from Bangladesh have focused only on specific infection types or genes [12,13,14]. Furthermore, most diagnostic centres do not have access to precise tools for the resolution of different Acinetobacter species, which hinders the understanding of the association of various Acinetobacter species to nosocomial infections and hospital outbreaks. Due to the lack of genomic data from Bangladesh, there is also a dearth of understanding of the prevalence and resistance patterns of different Acinetobacter STs in the country.
In this study, we used WGS data and in vitro phenotypic assays to characterize extensively drug resistant (XDR) clinical Acinetobacter spp. belonging to various prominent clonal complexes (CCs) from Dhaka, Bangladesh. We also aimed to analyse the mobile genetic structures and genetic variations within these genomes to understand the genomic architecture of these clones.
Antimicrobial susceptibility profile of Acinetobacter spp.
Sixty-three Acinetobacter spp. isolates were collected from diverse clinical sources including tracheal aspirates (n = 32), endotracheal tube cultures (n = 2), throat swabs (n = 7), bile (n = 1), wound swab (n = 1), urine (n = 9), blood (n = 9) and unspecified clinical sources (n = 2) (Fig. 1). The strains originated from two diagnostic/healthcare centres located in Dhaka, Bangladesh: Dhaka Central International Medical College and Hospital (DCIMCH) and the Hormone Lab and Infertility Center (HLIC). Based on antibiotic susceptibility profiles, all presumptive colonies were multidrug resistant (MDR), with most displaying resistance to third and fourth generation cephalosporins (Additional Table 1). Out of the isolates, 84.1% (n = 53) were XDR and showed susceptibility to only polymyxins and tigecyclines. Most strains also displayed resistance against the carbapenems, imipenem (96.8%) and meropenem (93.6%). Susceptibility to polymyxins were high, however, two pan-drug resistant strains were found that exhibited resistance against colistin and polymyxin B (Fig. 1a and Additional Table 1). In addition, 28.6% (n = 18) of the isolates showed resistance against tigecycline. Most AMR phenotypes did not appear to be influenced by specimen/source type, although the percentage of tigecycline resistance was higher among urine and blood isolates (~ 53%) in comparison to respiratory isolates (~ 30%) (Fig. 1c). PCR-based amplification of gyrB gene fragments inferred all strains to belong to the ACB complex out of which 96.8% (n = 61) were detected as A. baumannii.
Sequencing statistics of 15 Acinetobacter genomes
A total of 15 strains were sequenced out of which 14 were confirmed as A. baumannii using the PCR amplification of gyrB gene, while one was a non-baumannii bacterium belonging to the ACB complex. Moreover, 10 strains were sequenced from DCIMCH and five from HLIC, while phenotypically 13 were XDR and two were MDR.
BLAST of 16S ribosomal gene fragments and subsequent average nucleotide identity (ANI) analysis confirmed 14 strains to be A. baumannii while the one ACB complex strain was discovered to be A. nosocomialis. Pan-core analysis of the 14 A. baumannii strains showed the core genome to contain 3909 genes and the pangenome to contain 8198 genes. Inclusion of the A. nosocomialis strain reduced the core genome size to 3847 genes and raised the pangenome size to 9531 genes. Assembly of the sequenced reads resulted in contig numbers varying from 75 to 202 and N50 values ranging from 55,790–141,320 bp (Table 1). The genome sizes of the 15 strains were ~ 3.6–4.0 Mb and the GC content ranged from 38.66–39.12%, values that are typical for Acinetobacter genomes. The A. nosocomialis strain had the lowest GC% (38.66%) out of all the strains while its genome size (3,939,631 bp) fell somewhere in the middle of the range. While one pan-drug resistant isolate had been sequenced along with the 15 strains of this study, the assembly revealed contaminations from a co-infection of Klebsiella spp., and therefore it was eliminated from the analysis.
Acinetobacter genomes belonged to prominent clonal clusters in Asia
Strains belonging to both A. baumannii and A. nosocomialis species were classified using Pasteur’s MLST scheme- the gold standard method for sequence typing both baumannii and non-baumannii isolates . The results showed six strains belonging to ST2, the central ST of clonal complex 2 (CC2) that corresponds to international clone IC2, as per PubMLST’s BURST analysis (Additional Fig. 1a). Two strains were ST1, belonging to CC1 or IC1. The dataset of this study had a total of four strains of CC10: one belonging to the ancestral ST10, and others belonging to ST23 and ST575, both of which are single locus variants (SLVs) of the former. The remaining two A. baumannii genomes of the study were classified as the following STs: ST459 which is an SLV of CC33 and a novel ST, respectively. The A. nosocomialis strain was of ST768, which is a central ST of a prominent clone for this species (Additional Fig. 1b).
In silico serological typing was also performed on the strains by determining the gene loci of the capsular polysaccharide (KL) and lipo-oligosaccharide (OCL). All ST1 and ST2 strains possessed the OCL locus type 1 (OCL1) while all four CC10 strains possessed OCL2 (Table 1). Much more diversity was observed in KL locus types with 10 different predicted KL types being distributed in the 15 isolates.
Phylogenetic analysis of 15 Acinetobacter genomes
For a thorough analysis of phylogenetic and clustering patterns, all publicly available A. baumannii strains belonging to any of the STs encountered in this study were included in the dataset (Additional Table 2). Since a large proportion of publicly available A. baumannii genomes were ST2, only a few randomly selected strains of that ST belonging to different sources were included. The core-genome SNP-based maximum likelihood tree generated from a total of ~ 300 A. baumannii strains showed the grouping of strains belongning to the same CC (Fig. 2a). However, no clear topological distinction between strains originating from different sources was observed.
While the goeBURST analysis of all existing A. baumannii STs could not connect the novel ST CRA-AC-05 to any clonal cluster network, the core-genome SNP tree placed the former next to CC33 member CRA-AC-04. Cluster analysis based on the accessory genome profiles of 70 selected ACB complex strains mostly concurred with the grouping pattern of the core-genome based phylogenetic tree (Additional Fig. 2). Within the main cluster, two distinct clades were observed, one containing CC10 and CC33 strains and the other containing the CC1 and CC2 subclades. CRA-AC-05 once again clustered next to CC33 strain CRA-AC-04, indicating high similarity in accessory gene content between them. The isolation sources of the strains, as colour-coded in Additional Fig. 2, also showed an intermixing of strains isolated from various anatomical sites.
BURST analysis of A. nosocomialis revealed ST768 to be a central ST and therefore an ancestral ST to its clone (Additional Fig. 1b). While the core-genome SNP tree of A. nosocomialis strains also did not depict any grouping pattern dependent on source of isolation, strains belonging to clonal clusters CC768 and CC782, the former of which contained NGCE1007, appeared to be predominant in Asia and less frequent elsewhere (Fig. 2b).
Acinetobacter ARG profiles correlate with ST and phenotype
All 14 A. baumannii genomes possessed different varieties of the intrinsic class C ARG blaADC, a gene missing from the A. nosocomialis strain, NGCE1007 (Fig. 3). Penicillin-hydrolyzing class A beta-lactamases (blaVEB-7, blaTEM-1, blaPER-7 and blaCARB-2) were limited to CC2 and CC10 strains while the class B MBL blaNDM-1 was only detected in CC1 strains and the A. nosocomialis strain, NGCE1007. All 15 genomes carried various CHDLs: while the XDR CC1, CC2 and CC10 A. baumannii genomes contained blaOXA-23, the MDR A. nosocomialis strain NGCE1007 was the sole carrier of the blaOXA-58 type. All A. baumannii strains, including carbapenem-susceptible CRA-AC-04 and CRA-AC-05, contained various types of blaOXA-51-like beta-lactamase genes. An inter-ST difference in ARG distribution was also observed. The ST1 strains were the sole carriers of blaOXA-69, sulfamethoxazole/trimethoprim resistance conferring gene dfrA1 and aminoglycoside resistance genes aac -Ia and aadA1. Several other ARGs that were unique to a particular ST in the dataset include: blaOXA-66 for ST2 strains, blaOXA-120 for ST459 strain CRA-AC-04, blaCARB-2 and blaOXA-144 for the two ST575 strains, and blaOXA-314 for the novel ST CRA-AC-05.
Moreover, the ARG profiles corroborated the phenotypic resistance characteristics of the strains (Fig. 3). For CRA-AC-04 and CRA-AC-05, the absence of any aminoglycoside resistance conferring genes was reflected in their susceptible AMR phenotype against the tested antibiotics of this class. These two strains also displayed susceptibility to carbapenems, thus agreeing with their AMR gene profile which did not contain blaOXA-23. In contrast to the other strains, these two strains along with A. nosocomialis strain NGCE1007 also displayed susceptibility to fluoroquinolones, however no differentiating ARG was observed in the other resistant genomes. Ten of the genomes carried various types of tet genes, however only NGCE924 possessed tetA which has been shown to reduce tigecycline susceptibility in A. baumannii . None of the analysed genomes carried tet(X), a recently characterised plasmid mediated tigecycline resistance gene family that has been reported in various Enterobacteriaceae .
Acinetobacter genomes possess a rich virulome
The genomes of the 15 sequenced strains were checked for the presence of 135 A. baumannii virulence genes as obtained from the Virulence Factor Database (VFDB) (Fig. 4). Overall, the 15 genomes possessed a rich assortment of virulence genes with all of them containing 46.67% (n = 63) of the virulence genes in the dataset. Out of all the virulence gene groups analysed, the Acinetobactin operon (bauFDCEBA, basABCDEFG, and barAB), which is necessary for activating A. baumannii’s iron chelating pathway, was the only gene cluster that was exclusively absent in the A. nosocomialis genome.
Bacterial adherence and biofilm production in Acinetobacter is mediated by several gene groups, such as the resistance-nodulation-cell division (RND) family efflux pump genes adeFGH, the Csu pili system genes (csuABCDE), the polysaccharide matrix producing pgaABCD locus, the type IV pilus (TFP) pil genes, the quorum sensing genes abaI/abaR and the biofilm associated protein gene bap [17,18,19]. In the phenotypic biofilm formation test, all strains produced mild to moderate biofilms with Specific Biofilm Formation (SBF) value between 0.11–0.89 (Additional Fig. 3). Nearly all of the genes in the pga and adeG clusters were present in all 15 Acinetobacter genomes while the csu operon was found missing from most of the strains belonging to CC10. The bap gene was found to be exclusive to ST2 strains. Moreover, based on SBF values and virulence gene distribution pattern, no clear correlation could be established between the phenotype and genotype of biofilm formation.
The capsular polysaccharide is a key feature of A. baumannii, that aids in its survival in different environments and protects the bacterium against host immune system action such as the serum complement . Among the genes involved with the production of capsular polysaccharide, the enzymatic machinery of pse and associated genes which metabolizes UDP-linked sugars were found to be missing from all strains apart from the four ST2 strains from HLIC that had been isolated from blood. Other genes involved in serum survival such as the penicillin-binding protein (pbpG) , outer membrane protein (ompA) were ubiquitously found in the genomes.
Other notable absences of gene groups included the heme utilization HemO gene cluster for A. nosocomialis strain NGCE1007 and the novel A. baumannii ST CRA-AC-05 and the type VI secretion system (T6SS) genes for NGCE924, CRA-AC-04 and CRA-AC-05.
Certain virulence genes display increased genetic variance
The relatively high frequency of virulence factors in the core genome of our dataset prompted us to analyse the level of genetic variance within these genes. This was estimated by calculating their SNP/bp ratios over three iterations to adjust for any bias introduced due to inclusion of the A. nosocomialis strain and VFDB reference genomes in the dataset. All 15 Acinetobacter genomes along with the VFDB reference was included in Set A, following where the A. nosocomialis strain NGCE1007 and the VFDB reference were iteratively eliminated from the dataset to produce Sets B and C.
The results revealed increased genetic variances within otherwise conserved operons of Acinetobacter spp. and A. baumannii. The Acinetobactin bauA for example, is a gene belonging to a highly conserved operon of A. baumannii and shows high variance with an SNP/bp ratio of 0.294 for Set C. As mentioned before, the TFP gene cluster formed part of Acinetobacter core genome. While other genes of this operon were shown to be genetically conserved, pilA showed high levels of divergence with SNP/bp ratios ranging from 0.432 to 0.468 across the three tested sets. In case of pilA, the increased SNP/bp values resulted from a highly variable tail-end region of the gene which has been well documented in previous literature . The UDP-N-acetylglucosamine 6-dehydrogenase gene tviB also showed elevated SNP/bp ratio at ~ 0.353 while the bap gene wasfound to be highly variant among the ST2 strains (SNP/bp ratio ~ 0.398).
Overall, the analysis also revealed that while most A. baumannii virulence operons were present in the A. nosocomialis strains, they exhibited genetic divergence from their corresponding A. baumannii operons causing SNP/bp ratio to rise above 0.1 in most cases.
Acinetobacter STs display varying levels of similarity to reference plasmids
BLAST search was performed of the 15 genomes against a reference database of 578 publicly available A. baumannii plasmids to estimate the length of the genomes that matched against known plasmid sequences. The fraction of matched genome length was treated as a measure of the genome’s receptivity to plasmidic DNA. The analysis revealed a correlation between ST and the level of shared gene content: among the 15 strains, the five ST2 strains had the highest amount of BLAST similarities in plasmidic gene content, accounting for 2.13–2.18 Mb or ~ 54% of their genomes (Fig. 5a). Another prevalent clone, ST1 on the other hand, had the lowest level of shared gene content, with both NGCE922 and NGCE923 possessing only ~ 31% of genetic similarity with other A. baumannii plasmids. A. nosocomialis NGCE1007 was most conservative to shared gene content and had only ~ 27% of its genome similar to A. baumannii plasmids.
The 15 strains were also matched against a database of 27 A. nosocomialis’s plasmids. However, in this case the shared gene content was much lower in comparison to A. baumannii plasmid database with A. nosocomialis strain NGCE1007 itself showing only ~ 5.59% similarity (Fig. 5b). A. baumannii NGCE927 (ST10), however, showed a comparable level of shared gene content to that of the A. nosocomialis strain (~ 5.41%). Among the remaining A. baumannii strains, the ST2 strains had the lowest level of shared gene content with A. nosocomialis plasmids (~ 2.84%), while the rest had slightly higher levels of shared gene content of ~ 3.31%.
Mobilome architecture of different Acinetobacter STs
Limitations of short reads obtained from Illumina sequencing meant that complete plasmid assemblies could not be obtained from the sequencing data. Hence, we opted for an annotation-based approach for the identification of putative integrative and conjugative elements (ICEs) and integrative and mobilizing elements (IMEs) within our genomes. For this, the assembled contigs or nodes of the genomes were first searched for replication initiation proteins. The nodes carrying these proteins were then further analysed to identify genetic factors that are commonly enriched in ICEs/IMEs including conjugation systems, mobilization proteins, and toxin-antitoxin systems. These nodes were also annotated for the presence of ARGs, virulence factors and insertion sequences (ISs).
Among the 15 genomes analysed, all CC2 strains barring NGCE921 carried the F-like conjugation system consisting of traG, traH, traN, trbC, traU, traW, traB, traL along with replication initiation proteins (Table 2). The four ST2 strains from HLIC contained a 35,030 bp node carrying the conjugation machinery, and it mapped against a 65,089 bp plasmid node obtained from the ST2 strain NGCE928 from DCIMCH. The 65,089 bp NGCE928 plasmidic node also contained the ISAba125-associated ARG aph (3′)-VIa. These CC2 genomes also carried a ~ 49,371 bp node containing two replication initiation proteins as well as the csu virulence operon and the ISEc29-ISEc28-ISAba24 associated armA-msr(E)-mph(E) ARGs (Fig. 5c). All ST1 (CC1) and ST2 (CC2) strains contained a ~ 8088 bp node while the two ST575 (CC33) contained a ~ 17,000 bp node, both carrying two replicase proteins (Fig. 5c). Analysis via ICEfinder , also revealed the CC1 genomes and all CC10 genomes barring NGCE924 to carry putative IMEs consisting of genes coding for mobilization proteins MobA/MobL and integrases. However, no ARGs or virulence factors were found associated with them.
Identification of ISs within genomes, using ISFinder revealed the 15 strains to contain a myriad of ISs (Additional Fig. 4), many of which were found to be linked with ARGs (Fig. 5d). The ISAba1 insertion was found flanking blaOXA-23 for all genomes carrying the gene. On the other hand, for the ST1 strains and A. nosocomialis NGCE1007, the blaNDM-1 gene was carried in a 6388–8076 bp node. The blaNDM-1 gene was preceded by ISAba125 upstream and followed by the TnAs3 transposase downstream. It was also observed that the TnAs3 family transposase played a role in the genetic arrangements of the class A family beta-lactamases blaPER-7 and blaCARB-2, the aminoglycoside resistance conferring gene armA and the sulbactam resistance conferring gene sul1 in the CC10 strains, thus contributing to diversity in genetic structures within this resistance island.
Carbapenem resistant A. baumannii (CRAB) have become globally rampant in hospital ICUs, challenging empirical treatment conventions and necessitating the use of toxic, last-line therapies such as colistin . The strains of this study displayed high rates of resistance against carbapenems (> 90%), and most other drugs. The frequency of susceptibility to colistin was high, suggesting it can be an effective treatment option ad interim. However, the occurrence of colistin-resistant strains in our samples adds to the growing body of reports of pan-drug resistant A. baumannii in the subcontinent [25, 26]. Rising rates of tigecycline resistance among CRAB in recent years is another growing area of concern and our study concurs with recent reports demonstrating the growing frequency of tigecycline resistant CRAB around the world [27, 28]. Altogether the AMR profiles of strains reinstated the escalating prevalence of extensive drug resistance in Acinetobacter spp. in Bangladesh, thus necessitating reforms in healthcare delivery, including antibiotic stewardship and enhanced infection control.
All XDR A. baumannii genomes analysed in this study fell into CC1, CC2 or CC10, all three of which are prominent A. baumannii clones circulating in Asia (Additional Fig. 1a). In addition, this study also reports two MDR strains CRA-AC-04 and CRA-AC-05, which shared greater genetic proximity with CC10 strains, as per both core-genome phylogeny and accessory genome based hierarchical clustering pattern. A number of recent genomic and molecular typing studies originating from China and Southeast Asia have reported on the overwhelming dominance of ST2/CC2 strains in their A. baumannii population, while CC1 was found to be completely absent [29, 30]. On the contrary, several Indian studies have reported both CC1 and CC2 strains, albeit the latter was more frequent [31, 32]. While CC2 is ubiquitously predominant across the world, MLST data shows CC1 distribution to be more concentrated in North and South American nations. Our findings, taken together with other studies from neighbouring regions highlight the relatively greater abundance of CC1 in the Indian subcontinent in comparison to Southeast Asian countries. This, taken together with the discovery of several A. baumannii genomes belonging to another prevalent Asian clone CC10 and a prevalent A. nosocomialis ST (ST768) within our small pool of isolates, can be considered evidence towards the diversity of Acinetobacter strains within the country.
Acinetobacter spp.’s XDR phenotype is attributed to its genome harboring a wide range of beta-lactamase genes. CHDLs are thought to be the primary genetic determinants of carbapenem resistance. All of our A. baumannii strains that carried blaOXA-23 were phenotypically resistant to the carbapenems imipenem and meropenem whereas strains CRA-AC-04 and CRA-AC-05 lacking them were susceptible to these antibiotics. A. nosocomialis lacked blaOXA-23 but carried blaOXA-58 suggesting the latter gene might be a key genetic factor behind carbapenem resistance in the species. The class B1 MBL gene blaNDM-1, another contributor to carbapenem resistance, is particularly prevalent in South Asia and neighbouring regions. Among our strains, blaNDM-1 was found in both the ST1 strains and the A. nosocomialis isolate, but in none of the ST2 strains. Despite lower abundance of A. baumannii IC1 and A. nosocomialis in the clinical setting, these findings highlight their importance in Acinetobacter AMR epidemiology.
While various studies have implicated the roles of tet(X) family genes and tetA in tigecycline resistance, they were either absent or rare in the genomes analysed in this study. Other reports have identified the overexpression of RND efflux pumps and increased levels of mutations in associated genes as the predominant mechanism of tigecycline resistance in CRAB [28, 33]. Through genetic variation analysis we were able to detect high levels of mutations in tviB, supporting a recent report which also links it to reduced tigecycline susceptibility .
Virulence mechanisms such as biofilm formation are also strongly linked to the AMR phenotype of Acinetobacter spp., and often dictate their success as a nosocomial pathogen in hospital ICUs and NICUs. Although the sample size was too small to draw significant conclusions regarding ST-, source-, and location-specific differences in expressed virulence phenotypes, the strains of this study displayed moderate levels of biofilm formation that is comparable to other published works [34, 35]. Most genomic studies on A. baumannii report the ubiquity of virulence factors in its genome, irrespective of infection type and source. In this study too, most genomes were found to be highly enriched with virulence genes. However, the enhanced genetic variability within certain genes of otherwise conserved operons indicates a more complex mechanism of virulence as opposed to a direct causal relationship between gene presence/absence and virulence potential. Further studies on these genetic variabilities could elucidate whether they influence expressional changes in gene clusters involved in Acinetobacter’s virulence pathways.
Mobile genetic elements (MGEs) such as plasmids, ICEs, IMEs and ISs partake in horizontal gene transfer and are thus the regulators of the dissemination of virulence and resistance islands among Acinetobacter strains. Acinetobacter’s plasmidic structures and lineages have been difficult to comprehend due their diversity in terms of composition and size . CC2/IC2 strains possessed highest plasticity to A. baumannii plasmidic contents while CC1/IC1 had the lowest, thus showing differing levels of genetic content received from A. baumannii plasmids in these two international clones. Moreover, the ST10 strain NGCE927 also revealed similarity to A. nosocomialis plasmid databases that was at a comparable level to that of the A. nosocomialis strain of this study. Out of the 15 studied genomes we also observed five out of six CC2 genomes to carry a conjugation machinery that was missing in other strains. The study also highlighted the role of ISs in altering the spatial arrangements of ARGs as seen with the transposon TnAs3 among CC10 isolates. Taken together, these insights further support the dynamicity of Acinetobacter’s mobilomic structure both between and within CCs.
While we managed to contribute on the genomic structures of Bangladeshi Acinetobacter STs belonging to prominent clones, the study is limited by its small sample size. Overall, there is also the need to study probable associations between genetic variances and observed virulence through more in-depth phenotypic analyses and knockout assays. Furthermore, in our study we were only able to analyse putative ICEs/IMEs and draw associations between ISs and ARGs. With different sequencing techniques becoming accessible across the world, hybrid assemblies using short and long reads could be implemented to capture the genetic organization of larger MGEs such as plasmids and accurately resolve the precise genetic environments of important ARGs such as carbapenem resistance genes of the blaOXA family.
In this first-ever comparative genomics study on clinical Acinetobacter isolates from Bangladesh, we shed light on the presence of prominent clonal complexes of XDR Acinetobacter spp. in the country and reveal genomic insights on their ARGs and virulence factors. In addition, this study also highlights the role of ICEs and ISs in the dissemination of ARGs and virulence factors in Acinetobacter spp. The findings of this study are an important standpoint in understanding the epidemiology of Acinetobacter infections and their genomic characteristics pertaining to virulence, AMR and MGE activity in the subcontinent. Future genomic studies with a larger sample size and more in-depth analysis of phenotypes will be key in understanding the pathogenesis and resistance mechanisms of clinical Acinetobacter spp.
Sample collection, antibiotic susceptibility testing and PCR
Fifty-eight clinical isolates of Acinetobacter spp. were collected from inpatients admitted into the ICU, NICU, high dependency units and general medical wards of DCIMCH, Dhaka, Bangladesh, as well as from outpatients visiting the clinic for diagnostic purposes. In addition, five other ACB strains originating from blood samples were acquired from HLIC, an independent diagnostic laboratory in Dhaka. The isolates were collected from various clinical sources as listed in Additional Table 1. All samples were cultured on MacConkey agar (Oxoid, USA), following which biochemical tests were carried out for presumptive identification of Acinetobacter spp. The samples were then grown in T1N1 soft agar and transferred to North South University Genome Research Institute (NGRI), Dhaka, Bangladesh for further molecular and genomic characterization.
For all antibiotics except for the polymyxins and tigecycline, the CLSI’s disc diffusion breakpoints for Acinetobacter spp. were used . Broth microdilution was carried out for polymyxins and tigecycline using the recommended guidelines by CLSI and EUCAST respectively. To interpret the results for polymyxins, CLSI’s recommended breakpoints for Acinetobacter spp. were used (S < 2, and R > 4). In case of tigecycline, since no breakpoints are available for Acinetobacter spp., the EUCAST breakpoints for Enterobacterales were used (S < 0.5, R > 0.5) .
For further molecular confirmation for the ACB complex, DNA was extracted from the cultures of all 63 strains using QIAamp® DNA Mini Kit (Qiagen, Germany) and a conventional PCR assay was performed involving the gyrB gene fragments to identify ACB complex strains .
Sequencing, assembly and annotation
A subset of strains was selected for WGS, covering the two centres and varying time-points, sources and AMR phenotypes. Barcoded libraries were prepared using the Illumina DNA Prep workflow and Nextera DNA CD indexes. Paired end sequencing of 2 × 151 cycles was performed on Illumina MiSeq at NGRI. The raw reads were assembled using SPAdes version 3.15.1 , with a coverage cut-off of 20x and contigs shorter than 300 bp filtered out. The assembled genomes were annotated using Prokka . The isolates were genotyped in silico using the Pasteur scheme of Acinetobacter spp. MLST . The genomic resistance profiles of the strains were uncovered using the ResFinder tool (identity > 90%, coverage > 60%). The genes identified as beta-lactamases by ResFinder were further analysed by performing BLASTx on them against the Beta-Lactamase DataBase (BLDB) in order to correctly identify their gene numbers [43, 44]. VFDB was used to identify virulence genes within the genomes (e-value cut-off 1e− 5, identity > 60%, coverage > 90%) , and Acinetobacter KL and OCL loci were identified using Kaptive . Genetic variations within selected virulence genes were analysed using DnaSP following alignment of genes with MAFFT [47, 48]. Putative ICEs and IMEs were predicted using a combination of the online tool ICEfinder , and BLAST. Insertion sequences (ISs) and transposons were identified using ISFinder with e-value cut-off of 1e− 5 .
Pan-core, clonal complex, and phylogenetic analysis
Auxilliary information of all publicly avaible A. baumannii and A. nosomialis strains were collected from PATRIC (up until December 2nd, 2021, . Based on their Pasteur MLST allelic profile, a clonal complex network was built using goeBURST .
Pan-core genome analysis of strains was carried out using Roary , and a cluster dendrogram based on the presence-absence of accessory genes was generated using the Pvclust package of R which used bootstrap resampling (n = 1000) to generate p-values . Separate phylogenetic trees were generated for A. baumannii and A. nosocomialis using the strains sequenced in this study along with representative strains obtained from NCBI (Additional Tables 2 and 3). For this, quick core genome alignments were obtained from the PRANK and MAFFT programs of Roary following which single nucleotide polymorphism (SNP) sites were obtained from the core genome alignment using SNP-sites . Maximum likelihood trees were then built using the ultrafast bootstrapping option of IQTree with 1000 replicates . The resulting trees were visualized and edited with iTOL .
Assembled whole genomes of the strains were also checked for shared gene content with other available A. baumannii and A. nosocomialis plasmids by performing a BLAST search using an e-value threshold of 10− 20 against a database of 578 A. baumannii plasmids and 27 A. nosocomialis plasmids downloaded from NCBI (Additional Table 4).
Biofilm formation assay
Biofilm formation assay was performed using a slightly altered version of the previously described protocol . Briefly 2 μL of overnight cultures grown in Luria-Bertani (LB) broth were inoculated in 198 μL of fresh LB in sterile microtiter plates with four replicates per strain. 200 μL LB without any inoculum was used as a blank. The plates were incubated overnight at 37 °C following which the optical density at 600 nm (OD600nm) was measured (GloMax Explorer, Promega). The cultures were then discarded and the wells were rinsed twice with 1X phosphate buffered saline (pH 7.4). The plates were air dried and then stained for 15 minutes in 250 μL of 0.1% crystal violet (w/v). The stained biofilm cells attached to the well walls were then released in 200 μL of 33% glacial acetic acid and the plates were read at 560 nm. Due to no universally recognized system existing for evaluation of Acinetobacter biofilm formation level, for this study we opted to measure biofilm forming propensity using specific biofilm formation (SBF) value that was described in a previous study . Here, SBF = (AB – CW)/G, where AB is OD560nm of stained cells, CW is OD560nm of control wells, and G is bacterial cell growth calculated using the formula G = OD600nm(24 hr) – OD600nm(0 hr). Strains with SBF value below 0.5 was categorized as mild biofilm formers, those with SBF 0.5 or greater, but less than 1 were categorized as moderate biofilm formers and those with SBF value of 1 or greater were labelled as strong biofilm formers. The entire experiment was repeated twice.
Availability of data and materials
The genomic sequence data generated in this study have been submitted to NCBI’s GenBank repository (https://www.ncbi.nlm.nih.gov/genbank/) under the accession numbers JAKRBR000000000 to JAKRCF0000000000, as indicated in Additional Table 5.
Acinetobacter calcoaceticus-A. baumannii
Intensive care unit
Carbapenem-hydrolyzing class D beta-lactamase
Whole genome sequencing
Extensively drug resistant
Dhaka Central International Medical College and Hospital
Hormone Lab and Infertility Center
Average nucleotide identity
Single locus variants
Virulence Factor Database
Type IV pilus
Specific Biofilm Formation
Integrative and conjugative element
Integrative and mobilizing element
Mobile genetic element
Single nucleotide polymorphism
Sarjana Safain K, Bhuyan GS, Hassan Hasib S, Islam MS, Mahmud-Un-Nabi MA, Sultana R, et al. Genotypic and phenotypic profiles of antibiotic-resistant bacteria isolated from hospitalised patients in Bangladesh. Tropical Med Int Health. 2021;26(7):720–9.
Fitzpatrick MA, Ozer E, Bolon MK, Hauser AR. Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance. J Inf Secur. 2015;70(2):144–52.
Nemec A, Krizova L, Maixnerova M, Sedo O, Brisse S, Higgins PG. Acinetobacter seifertii sp. nov., a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated from human clinical specimens. Int J Syst Evol Microbiol. 2015;65:934–42.
Piperaki ET, Tzouvelekis LS, Miriagou V, Daikos GL. Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment. Clin Microbiol Infect. 2019;25(8):951–7.
Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol. 2019;1(10):539.
Yang CH, Su PW, Moi SH, Chuang LY. Biofilm formation in Acinetobacter Baumannii: genotype-phenotype correlation. Molecules. 2019;24(10):1849.
Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013;41(1):11–9.
Halachev MR, Chan JZM, Constantinidou CI, Cumley N, Bradley C, Smith-Banks M, et al. Genomic epidemiology of a protracted hospital outbreak caused by multidrug-resistant Acinetobacter baumanniiin Birmingham, England. Genome Med. 2014;6:70.
Leal NC, Campos TL, Rezende AM, Docena C, Mendes-Marques CL, de Sá Cavalcanti FL, et al. Comparative genomics of Acinetobacter baumannii clinical strains from Brazil reveals polyclonal dissemination and selective exchange of Mobile genetic elements associated with resistance genes. Front Microbiol. 2020;17(11):1176.
Liu F, Zhu Y, Yi Y, Lu N, Zhu B, Hu Y. Comparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinants. BMC Genomics. 2014;15(1):1163.
Ahmed D, Nahid MA, Sami AB, Halim F, Akter N, Sadique T, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005–2014. Antimicrob Resist Infect Control. 2017;6(1):2.
Ferdous J, Murshed M, Shahnaz S, Duza SS, Siddique PR. Isolation of Acinetobacter species and their antimicrobial resistance pattern in a tertiary care hospital in Dhaka. Bangladesh Bangladesh J Med Microbiol. 2017;10(1):18–21.
Khatun N, Farzana R, Lopes BS, Shamsuzzaman SM. Molecular characterization and resistance profile of nosocomial Acinetobacter baumannii in intensive care unit of tertiary care hospital in Bangladesh. Bangladesh Med Res Counc Bull. 2016;41(2):101–7.
Nahar A, Anwar S. Miah MdRA. Association of Biofilm Formation with antimicrobial resistance among the Acinetobacter species in a tertiary care hospital in Bangladesh. J Med. 2013;14(1):28–32.
Foong WE, Wilhelm J, Tam HK, Pos KM. Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters. J Antimicrob Chemother. 2020;75(5):1135–9.
Chen C, Cui CY, Yu JJ, He Q, Wu XT, He YZ, et al. Genetic diversity and characteristics of high-level tigecycline resistance Tet(X) in Acinetobacter species. Genome Medicine. 2020;12(1):111.
Wang X, Preston JF, Romeo T. The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide Adhesin required for biofilm formation. J Bacteriol. 2004 May;186(9):2724–34.
Pakharukova N, Tuittila M, Paavilainen S, Malmi H, Parilova O, Teneberg S, et al. Structural basis for Acinetobacter baumannii biofilm formation. Proc Natl Acad Sci U S A. 2018;115(21):5558–63.
Tang J, Chen Y, Wang X, Ding Y, Sun X, Ni Z. Contribution of the AbaI/AbaR quorum sensing system to resistance and virulence of Acinetobacter baumannii clinical strains. IDR. 2020;13:4273–81.
Singh JK, Adams FG, Brown MH. Diversity and Function of Capsular Polysaccharide in Acinetobacter baumannii. Frontiers in Microbiology [Internet]. 2019 [cited 2022 Mar 23];9. Available from: https://www.frontiersin.org/article/10.3389/fmicb.2018.03301
Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Frontiers in Cellular and Infection Microbiology 2017 [cited 2022 Mar 23];7. Available from: https://www.frontiersin.org/article/10.3389/fcimb.2017.00055
Ronish LA, Lillehoj E, Fields JK, Sundberg EJ, Piepenbrink KH. The structure of PilA from Acinetobacter baumannii AB5075 suggests a mechanism for functional specialization in Acinetobacter type IV pili. J Biol Chem. 2019;294(1):218–30.
Liu M, Li X, Xie Y, Bi D. ICEberg 2.0: an updated database of bacterial integrative and conjugative elements | Nucleic Acids Research | Oxford Academic [Internet]. [cited 2022 Apr 2]. Available from: https://academic.oup.com/nar/article/47/D1/D660/5165266
Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, et al. Task force on management and prevention of Acinetobacter baumannii infections in the ICU. Intensive Care Med. 2015 Dec;41:2057–75.
Wongsuk T, Boonsilp S, Homkaew A, Thananon K, Oonanant W. Whole genome sequence of pan drug-resistant clinical isolate of Acinetobacter baumannii ST1890. PLoS One. 2022;17(3):e0264374.
Miltgen G, Bour M, Allyn J, Allou N, Vedani T, Vuillemenot JB, et al. Molecular and epidemiological investigation of a colistin-resistant OXA-23−/NDM-1-producing Acinetobacter baumannii outbreak in the Southwest Indian Ocean area. Int J Antimicrob Agents. 2021;58(4):106402.
Kim WY, Moon JY, Huh JW, Choi SH, Lim CM, Koh Y, et al. Comparable efficacy of Tigecycline versus Colistin therapy for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii pneumonia in critically ill patients. PLoS One. 2016;11(3):e0150642.
Lucaßen K, Müller C, Wille J, Xanthopoulou K, Hackel M, Seifert H, et al. Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey. J Antimicrob Chemother. 2021;76(7):1724–30.
Khuntayaporn P, Kanathum P, Houngsaitong J, Montakantikul P, Thirapanmethee K, Chomnawang MT. Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study. Ann Clin Microbiol Antimicrob. 2021;20(1):19.
Zhang X, Li F, Awan F, Jiang H, Zeng Z, Lv W. Molecular epidemiology and clone transmission of Carbapenem-resistant Acinetobacter baumannii in ICU rooms. Frontiers in Cellular and Infection Microbiology [Internet]. 2021 [cited 2022 Mar 27];11. Available from: https://www.frontiersin.org/article/10.3389/fcimb.2021.633817
Rose S, Shamanna V, Underwood A, Nagaraj G, Prasanna A, Govindan V, et al. Molecular dissection of carbapenem-resistant Acinetobacter baumannii circulating in Indian hospitals using whole genome sequencing [internet]. Genomics; 2021 Jul [cited 2022 Jan 17]. Available from: http://biorxiv.org/lookup/doi/10.1101/2021.07.30.454432
Vijayakumar S, Mathur P, Kapil A, Das B, Ray P, Gautam V, et al. Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India. Indian J Med Res. 2019;149(2):240.
Gerson S, Nowak J, Zander E, Ertel J, Wen Y, Krut O, et al. Diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with tigecycline resistance in Acinetobacter baumannii. J Antimicrob Chemother. 2018;73(6):1501–8.
Yu K, Zeng W, Xu Y, Liao W, Xu W, Zhou T, et al. Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China. Antimicrob Resist Infect Control. 2021;10(1):16.
Kim J, Lee JY, Lee H, Choi JY, Kim DH, Wi YM, et al. Microbiological features and clinical impact of the type VI secretion system (T6SS) in Acinetobacter baumannii isolates causing bacteremia. Virulence. 2017;8(7):1378–89.
Salgado-Camargo AD, Castro-Jaimes S, Gutierrez-Rios RM, Lozano LF, Altamirano-Pacheco L, Silva-Sanchez J, et al. Structure and evolution of Acinetobacter baumannii plasmids. Front Microbiol. 2020;18(11):1283.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. CLSI Approved Standard M100-S15. Wayne: Clinical and Laboratory Standards Institute; 2018.
EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 12.0. 2022. [Internet]. [cited 2022 Sep 28]. Available from: https://www.eucast.org/clinical_breakpoints
Higgins PG, Wisplinghoff H, Krut O, Seifert H. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect. 2007;13:1199–201.
Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455–77.
Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–9.
Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool. Ahmed N, editor. PLoS One. 2010;5(4):e10034.
Naas T, Oueslati S, Bonnin RA, Dabos ML, Zavala A, Dortet L, et al. Beta-lactamase database (BLDB) – structure and function. Journal of Enzyme Inhibition and Medicinal Chemistry. 2017;32(1):917–9.
Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67:2640–4.
Chen L, Yang J, Yu J, Yao Z, Sun L, Shen Y, et al. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res. 2005;33:D325–8.
Wyres KL, Cahill SM, Holt KE, Hall RM, Kenyon JJ. Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive. Microbial Genomics [Internet]. 2020 Mar 1 [cited 2022 Jan 17];6(3). Available from: https://www.microbiologyresearch.org/content/journal/mgen/10.1099/mgen.0.000339
Katoh K. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 2005;33(2):511–8.
Rozas J, Ferrer-Mata A, Sánchez-DelBarrio JC, Guirao-Rico S, Librado P, Ramos-Onsins SE, et al. DnaSP 6: DNA sequence polymorphism analysis of large data sets. Mol Biol Evol. 2017;34:3299–302.
Siguier P. ISfinder: the reference Centre for bacterial insertion sequences. Nucleic Acids Res. 2006;34(90001):D32–6.
Davis JJ, Wattam AR, Aziz RK, Brettin T, Butler R, Butler RM, et al. The PATRIC bioinformatics resource center: expanding data and analysis capabilities. Nucleic Acids Res. 2020;48(D1):D606–12.
Francisco AP, Bugalho M, Ramirez M, Carriço JA. Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach. BMC Bioinformatics. 2009;10(1):152.
Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31(22):3691–3.
Pvclust: an R package for assessing the uncertainty in hierarchical clustering | Bioinformatics | Oxford Academic [Internet]. [cited 2022 Jan 17]. Available from: https://academic.oup.com/bioinformatics/article/22/12/1540/207339
Page AJ, Taylor B, Delaney AJ, Soares J, Seemann T, Keane JA, et al. SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments. Microb Genom. 2016;2(4):e000056.
Hoang DT, Chernomor O, von Haeseler A, Minh BQ, Vinh LS. UFBoot2: improving the ultrafast bootstrap approximation. Mol Biol Evol. 2018;35(2):518–22.
Letunic I, Bork P. Interactive tree of life (iTOL) v4: recent updates and new developments. Nucleic Acids Res. 2019;47(W1):W256–9.
O’Toole GA. Microtiter Dish Biofilm Formation Assay JoVE. 2011;30(47):2437.
Nandanwar N, Janssen T, Kühl M, Ahmed N, Ewers C, Wieler LH. Extraintestinal pathogenic Escherichia coli (ExPEC) of human and avian origin belonging to sequence type complex 95 (STC95) portray indistinguishable virulence features. Int J Med Microbiol. 2014;304(7):835–42.
We thank North South University for funding the project and DCIMCH and HLIC for providing the samples.
This work was funded by North South University Conference Travel and Research Grants (NSU CTRG) Committee under the grant number: NSU-RP-18-042.
Ethics approval and consent to participate
All isolates used in this study were obtained for diagnostic purposes from a local diagnostic centre and a hospital where pathogens are isolated from clinical specimens as part of standard diagnostic procedures. All experimental protocols were approved by the North South University (NSU) Institutional Review Board (IRB) /Ethical Review Committee (ERC) under the protocol number CTRG: NSU-RP-18-042. All experiments were carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from all subjects and/or their legal guardian(s).
Consent for publication
The authors have no competing interests to declare that are relevant to the content of this article.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Additional file 1.
Additional file 2.
Table S1. Antimicrobial susceptibility of 63 clinical Acinetobacter spp. strains isolated from Dhaka, Bangladesh.
Additional file 3
Table S2. Global Acinetobacter baumannii strains used for pholygenetic analysis.
Additional file 4
Table S3. Global Acinetobacter nosocomialis strains used for pholygenetic analysis.
Additional file 5
Table S4. NCBI accessions of plasmid sequences of A. baumannii and A. nosocomialis.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Rahman, A., Styczynski, A., Khaleque, A. et al. Genomic landscape of prominent XDR Acinetobacter clonal complexes from Dhaka, Bangladesh. BMC Genomics 23, 802 (2022). https://doi.org/10.1186/s12864-022-08991-x
- Acinetobacter baumannii
- Acinetobacter nosocomialis
- Clonal complex
- Comparative genomics